Prevalence, Characteristics, and Long-Term Prognosis of Epilepsy Associated with Pediatric Brain Tumors

Hadar Weisman1, Iris Fried1, Tal Gilboa2

  • 1Hematology-Oncology Department, Hadassah Ein Kerem Medical Center, Jerusalem, Israel.

World Neurosurgery
|October 22, 2017
PubMed

Insights

Epilepsy is common in children with brain tumors, with 18% developing it after surgery. While long-term seizure control is good, new-onset epilepsy after surgery is linked to poorer neurological outcomes.

Area of Science:

  • Pediatric Neurology
  • Neuro-oncology
  • Epileptology

Background:

  • Epilepsy is a significant comorbidity in pediatric brain tumor patients.
  • Understanding the incidence and long-term outcomes of epilepsy post-surgery is crucial for patient management.

Purpose of the Study:

  • To determine the prevalence, onset, characteristics, and long-term course of epilepsy in children undergoing surgical treatment for brain tumors.
  • To analyze the relationship between epilepsy onset and neurological outcomes.

Main Methods:

  • Retrospective review of medical records for children with brain tumors treated surgically (2004-2014).
  • Inclusion of patients with epilepsy for clinical visits and neurological examinations.
  • Assessment of neurological status using the Glasgow Outcome Score (GOS) and seizure control using the Engel system.

Main Results:

  • 34% of 128 patients experienced seizures; 18% developed epilepsy post-surgery.
  • Among survivors with epilepsy, 70% achieved Engel class I seizure control.
  • Post-surgical epilepsy onset correlated with a less favorable neurological outcome (GOS 1-2).
  • Cortical tumors and gross total resection were associated with seizure risk.

Conclusions:

  • Epilepsy has a high incidence in the long-term course of pediatric brain tumor disease.
  • While seizure outcomes are generally excellent, post-surgical epilepsy onset indicates a poorer neurological prognosis.
  • Further research into preventative and management strategies for post-surgical epilepsy is warranted.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.4K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.8K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
982